Scilex Holding Company (SCLXW)

USD 0.21

(-23.88%)

Operating Income Summary of Scilex Holding Company

Scilex Holding Company's latest annual operating income in 2023 was -105.43 Million USD , down -108.22% from previous year.
Scilex Holding Company's latest quarterly operating income in 2024 Q2 was -15.62 Million USD , up 40.75% from previous quarter.
Scilex Holding Company reported an annual operating income of -50.63 Million USD in 2022, down -41.29% from previous year.
Scilex Holding Company reported an annual operating income of -35.83 Million USD in 2021, down -1.65% from previous year.
Scilex Holding Company reported a quarterly operating income of -15.62 Million USD for 2024 Q2, up 40.75% from previous quarter.
Scilex Holding Company reported a quarterly operating income of -25.47 Million USD for 2023 Q1, down -29.04% from previous quarter.

Annual Operating Income Chart of Scilex Holding Company (2023 - 2019)

Historical Annual Operating Income of Scilex Holding Company (2023 - 2019)

Year	Operating Income	Operating Income Growth
2023	-105.43 Million USD	-108.22%
2022	-50.63 Million USD	-41.29%
2021	-35.83 Million USD	-1.65%
2020	-35.25 Million USD	74.58%
2019	-138.69 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-26.36 Million USD	-43.79%
2024 Q2	-15.62 Million USD	40.75%
2023 Q1	-25.47 Million USD	-29.04%
2023 Q3	-38.8 Million USD	-70.09%
2023 Q2	-22.81 Million USD	10.44%
2023 FY	-105.43 Million USD	-108.22%
2023 Q4	-18.33 Million USD	52.74%
2022 Q2	-11.47 Million USD	-30.26%
2022 Q1	-8.8 Million USD	-2188.1%
2022 FY	-50.63 Million USD	-41.29%
2022 Q4	-19.74 Million USD	-85.96%
2022 Q3	-10.61 Million USD	7.45%
2021 FY	-35.83 Million USD	-1.65%
2021 Q1	-8.95 Million USD	-1.65%
2021 Q4	-384.86 Thousand USD	-35.82%
2021 Q3	-283.35 Thousand USD	96.84%
2021 Q2	-8.95 Million USD	0.0%
2020 Q3	-8.81 Million USD	0.0%
2020 Q1	-8.81 Million USD	74.58%
2020 FY	-35.25 Million USD	74.58%
2020 Q4	-8.81 Million USD	0.0%
2020 Q2	-8.81 Million USD	0.0%
2019 Q2	-34.67 Million USD	0.0%
2019 Q3	-34.67 Million USD	0.0%
2019 FY	-138.69 Million USD	0.0%
2019 Q1	-34.67 Million USD	0.0%
2019 Q4	-34.67 Million USD	0.0%

Peer Operating Income Comparison of Scilex Holding Company

Name	Operating Income	Operating Income Difference
Amgen Inc.	7.89 Billion USD	101.335%
AstraZeneca PLC	8.19 Billion USD	101.287%
Biogen Inc.	1.29 Billion USD	108.13%
Gilead Sciences, Inc.	7.6 Billion USD	101.386%
MIRA Pharmaceuticals, Inc.	-8.52 Million USD	-1136.575%
Scilex Holding Company	-105.43 Million USD	-0.0%